leisure time -WSS

leisure time

author：fashion 2025-09-28 21:06:59 - browse：6777

Transparent plastic divider on the reception desk in the hospital admission department with red lettering emergency. — Adobe

QuidelOrtho has recalled nearly 8,000 potentially faulty blood tests meant to help doctors quickly determine whether a patient is having a heart attack.

The tests inaccurately showed low levels of troponin, a protein that indicates damage to the heart. A false negative could lead doctors to mistakenly conclude their patient is not having a heart attack, delaying diagnosis or treatment when time is of the essence.

The device maker, which also sells products like the QuickVue Covid-19 antigen test, sent letters to health systems in May telling them to immediately stop using the test. The Food and Drug Administration classified the recall as serious, because problems with the product could result in serious injury or death. QuidelOrtho has reported 41 complaints, but no injuries or deaths so far.

The tests, which use either a blood or plasma sample, promise to return results in under half an hour. They are used in emergency rooms to triage patients suspected of having a heart attack.

Related: With Wegovy and Ozempic’s success, can device makers keep up in the race to treat obesity?

The FDA said the patients most at risk are those with zero or abnormal heart attack symptoms, for whom a diagnosis would be easy to miss without an accurate lab test.

The company advised using a different testing method to detect heart attacks. If none are available, doctors should be extra wary of the blood panel’s readings, perform multiple tests to confirm low troponin levels, and also reference data from EKGs and other imaging.

San Diego-based QuidelOrtho said the error is due to a “raw material issue” in its recall record. The issue caused the test to falsely pick up 30% less troponin than is present. The company did not respond to STAT’s request for more information on the error.

The test maker’s last serious recall was in 2021 for reports of false negatives from its Lyra PCR Covid-19 test when used with certain lab equipment. The notice impacted more than 18,000 test kits.

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Excited delirium, Elijah McClain, and emergency physicians

entertainment

focus

WSS

Security flaws in third

Lupron, used to halt puberty in children, may cause lasting health problems

More doctors should go into startup world

Ambulance rides for just $100? Advisers want major billing fixes

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Beware reading your test results before your doctor does

explore

leisure time

Related: With Wegovy and Ozempic’s success, can device makers keep up in the race to treat obesity?

hotspot

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

The wait for US passports is creating travel purgatory and snarling summer plans

Activists slam private health insurers over coverage restrictions

'Screen and refer' systems are hurting patients

What does generative AI mean for health care? We asked experts

Drug cartel violence flares in western Mexico after vigilante leader's killing

What does generative AI mean for health care? We asked experts

Biotech incubator Curie.Bio graduates its first startup

Activists slam private health insurers over coverage restrictions

A clever new way to fix Medicaid and graduate medical education

focus

Medicare solvency divides Republicans at the presidential debate

UpToDate has a racism problem: Dr. Stanley Goldfarb

The wait for US passports is creating travel purgatory and snarling summer plans

Beware reading your test results before your doctor does

A clever new way to fix Medicaid and graduate medical education

HPV cancer vaccine study demonstrates efficacy

entertainment

Wikipedia

focus

entertainment